More than 1,750 standalone Medicare Part D prescription drug plans will offer the lower insulin copays through the Part D Senior Savings Model for the 2021 plan year.
The $35 per month cap applies to both pen and vial dosage forms for rapid-acting, short-acting, intermediate-acting and long-acting insulin.
More than 3.3 million Medicare beneficiaries use one or more common forms of insulin, and they could see annual savings of about $446 for insulin, CMS said in a news release.
More articles on pharmacy:
AstraZeneca gets $1B from US to produce COVID-19 vaccine
7 things to know about startup drugmaker Phlow
Consumers still feel comfortable picking up prescriptions at pharmacies, survey says
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
